Shared under ten

You can follow our portfolio and take advantage of it. Our portfolio is not a buy recommendation.

Analysis: Buy a dollar for 50 cents

Indian online travel agency Yatra Online successfully floated its subsidiary on the India Stock Exchange last September. This IPO allowed $21 million to be added to the coffers of Yatra itself, and $65 million to the coffers of the subsidiary. With this, both parent and subsidiary companies are now extremely well capitalized. Yatra still has a 65% interest in the subsidiary remaining after this IPO. This stake alone is worth nearly $220 million at the time of writing, while Yatra itself has a current market capitalization of less than $110 million. It therefore appears that there is significant undervaluation. Equity Undersecretary struck and included 1,000 shares of Yatra in its portfolio at the current price of US$1.47.

Share price movement Yatra Online over the past four years.

Profile

Note that fiscal years are broken, running from April 1 to March 31.

Yatra Online Inc was founded in 2006 by Dhruv Shringi (the current CEO), Manish Amin, and Sabina Chopra. The name Yatra means “travel” in Hindi, the most widely spoken language in India. The three founders knew each other from their careers at ebookers.com, where they held key technical and marketing positions. Armed with the knowledge they gained, they were able to create a functioning online travel agency in a short period of time. Within six years, Yatra already had a 30% market share in fast-growing India, ranking second only to MakeMyTrip. Yatra serves both the business segment and the consumer market, with an emphasis on the corporate market. The business market in India is particularly interesting because only 5% of all business travel is booked online, so there is still a lot of ground to be gained here. The combination of business travel and private travel is proving useful; in fact, business customers often turn out to book private travel with the same travel operator, and also vice versa, and so there is cross-pollination. Yatra appears to have a good reputation; not only is the name very well known in India, but customer reviews are remarkably positive, and the percentage of returning customers is high. Nevertheless, profit margins are low for now, which is due to the fragmented market in India, making competition very high. In time, consolidation should lead to less competition, and better profit margins.

Results over the past three years

Table 1 shows that the corona virus outbreak caused revenue to implode by a whopping 82% in broken fiscal year 2021, followed by recovery. Incidentally, the 2023 revenue of $46.6 million is still significantly lower than the $96.3 million recorded in the year before corona, and that means the company is still in the recovery phase. Air tickets accounted for 84% of the total booking amount for fiscal year 2023, followed by hotels with a 12% contribution, and other services with 4%. The margin of air tickets of 8% was over 2023 than the 13% margin of hotels. This is not surprising since competition in the airline ticket market is extremely high. By the way, the margin of other services at 6% is a bit on the low side, but it shows recovery over the first half of 2024.

Table 1: Results for the past three years. *before changes in working capital.

Results for the first half of 2024

Table 2 shows that the recovery in sales continues, with sales increasing faster than the total booking amount. This seems to indicate that margins are improving somewhat. Incidentally, the optically high net loss in the second quarter is largely due to the one-time costs of the subsidiary’s IPO in late September. In this respect, the net loss below the line was still quite contained at $0.05 per share. It is important, however, that the net loss decreases in the yet-to-be-published third-quarter figures. But more importantly: the operating cash flow before changes in working capital must become positive again as soon as possible, because it is not the intention that money should structurally leave the company.

Table 2: Results for the first half of 2024. *before changes in working capital.

The financial position

Table 3 shows balance sheet as of September 30, 2023 in U.S. dollars. Total debt is $21.0 million, and compares to a cash position of $57.7 million. This leaves the company with net assets of $36.7 million. When equity of $68.8 million is adjusted for intangible assets, a tangible book value of $59.1 million remains. That works out to $0.92 per share. In summary, this is a very solid balance sheet.

Table 3: Balance sheet as of September 30, 2023.

Appraisals

Table 4 shows the valuations for the next two years. Based on broken fiscal year 2025, an EV/ebitda multiple of 8.3x and a P/E ratio of 21.2x then rolls out. It is not expected that dividends will be paid in the foreseeable future.

Table 4: Valuations through 2025. *normalized.

Conclusion: buy-worthy around $1.50

Based on the valuation multiples just mentioned, investors will not be immediately inclined to run to their computers to enter a buy order. However, Yatra has been excellently capitalized since the successful IPO of its subsidiary and has good growth prospects. But regardless, there seems to be a particularly generous margin-of-safety. Indeed, Yatra’s 65% stake in its Indian subsidiary is already worth $220 million. However, net debt-free Yatra has a market capitalization of only $110 million, and that effectively means a dollar can be bought for 50 cents. We therefore consider the stock to be buyable and give it a price target of $3.40, which corresponds to its net asset value per share. Due to its relatively low market capitalization, an investment in Yatra should only be considered suitable for speculative investors. SharesUnion is therefore taking a position at half strength, which in our case amounts to 1,000 shares of Yatra at the current price of $1.47.

Author has position in Yatra at time of writing.

Key date
March 26, 2024: release third-quarter figures broken fiscal year 2024 (estimated)

Major shareholders
MAK Capital One: 19.0%
Altai Capital Management: 7.4%
Goldman Sachs: 7.0%
Timothy Maguire: 7.0%
Vinny Smith: 4.8%
Catamount Strategic Advisors: 3.7%
Acuitas Investments: 3.4%
Dhruv Shringi (CEO): 3.3%
Nathan Leight: 3.1%

Core data Yatra
Name: Yatra Online Inc
Ticker: YTRA
Sector: Travel
Stock Market: NASDAQ
ISIN: KYG983381099
Snapshot price: $1.70
52-week low: $1.40
52-week high: $2.67
US dollar/Indian rupee exchange rate: 83.0
Total shares outstanding: 64.2 million shares
Market capitalization: $109.2 million
Net assets: $36.7 million
Enterprise value (EV): $72.5 million
Tangible book value per share: $0.92
Share price/material book value: 1.8x
Net asset value (NAV): $220 million
NAV per share: $3.40
Heading/NAV: 0.5x
Dividend per share: $0.00
Website: investors.yatra.com

Verder lezen?

Dit artikel is alleen voor abonnees van Aandelen Onder Een Tientje. Indien u nog geen abonnee bent, overweegt u dan ook een abonnement.

Join thousands of others?

Become a member now and get instant access to our entire platform. 

The value we offer:

Lees ook

No posts found!

Analyse

We jump on the moving train…!

Yesterday we saw Avantium shares bounce back after a buy recommendation was issued. We are not hesitating, but are jumping on the train that has just started moving. The share has suffered greatly due to a large issue in which approximately €70 million was raised. Investors were disappointed and the price has collapsed! But what investors are overlooking in their frustration is that Avantium’s management has raised more than enough capital to finish their flagship, the FDCA factory in Delfzijl.  A number of very large companies have committed to purchasing the promising bioplastic or to producing it under license. This indicates that this is a potentially groundbreaking product. The share is trading almost at its lowest point of the year and now that the financial position is in order for the foreseeable future, the risk-return ratio seems to have improved to such an extent that speculative investors can consider an investment. According to the initial planning, the FDCA plant in Delfzijl should be operational by the end of 2023, but the misery on the labor market – combined with the sharp increase in inflation – threw a spanner in the works. Not only did the delivery date have to be postponed (to the second half of 2024), but additional financing was also needed. With the completion of the recent €70 million issue, the financing is now completely in place; management expects to have sufficient liquidity well beyond the moment that the plant will be operational. If the plant in Delfzijl is successfully operational in the second half of the year, management expects to be able to achieve a turnover of around €100 million in 2026, with the EBITDA coming in around zero. This means that from that moment on, no more money will be spent – ​​and Avantium therefore no longer needs to issue shares. In addition to two neutral recommendations, all other analysts have the share on “Buy”. The lowest and highest price targets are €2.40 and €9.57 respectively. The average price target is €5.24. Once the construction of the factory in Delfzijl is completed, it will be the first commercial FDCA factory in the world. If it succeeds before the end of the year, the share price will undoubtedly attract a lot of interest with sharply rising prices. Avantium has a market capitalization of only €170 million at the current price, but anyone who knows that the potential market is hundreds of billions also knows that there is a lot to be gained for the speculator. According to our expectation, the share price potential is between 100 and 400%, because if the FDCA factory in Delfzijl lives up to expectations, price targets of well above €10 can quickly be considered. We buy 1200 shares at €2.30 each.  Author has position

Lees verder >
Update

We bought Deceuninck for €2.27: Discover the latest developments

In this video, Rick van Zelst discusses Deceuninck stock, a leading company in the plastics sector. Sharesunderonetientje bought this stock at €2.27, and now it is around €2.45. Thanks to an optimized production process and signs of recovery in demand for plastics production, Deceuninck offers potential for significant margin improvement. Is this stock still worth it for your portfolio? Watch the video and judge for yourself!

Lees verder >
Update

Today we saw another increase on our top purchase, which now brings us towards a 25% profit.

HelloFresh (HELFY) saw a remarkable 13% rise on the Frankfurt stock exchange after announcing its second-quarter results that beat expectations. Despite a 3.1% drop in orders to 28.9 million and a 3.5% drop in meal deliveries to 243.8 million, the company still managed to impress. This was thanks to an impressive 5.4% increase in average order value to €67.10, which more than offset the volume declines. The Berlin-based company highlighted that this was the twelfth consecutive quarter of growth in average order value. This growth was mainly driven by a higher contribution from ready-to-eat products, an increase in premium and customizable meals, and a broader inclusion of market items. In addition, HelloFresh reduced price incentives in several product categories. HelloFresh also took significant steps to improve its production capacity, which however resulted in one-time, non-cash write-downs of €45 million in the first half of 2024, of which €32 million in the second quarter. Despite a 23% year-on-year decline in adjusted EBITDA to €146.4 million, the consensus estimate of €123 million was exceeded. Stocksunder100 see HelloFresh’s Ready-to-Eat (RTE) business performing strongly, now accounting for around a quarter of total group revenue. Free cash flow also remains strong, despite the second quarter historically being a period of lower volume. If you’ve already stocked up big, it may be wise to take a small portion of the profits. However, we believe the stock has even more potential and therefore choose to hold the full position.

Lees verder >